Back
Day Range
$75.36
$77.14
52-Week Range
$35.61
$94.15
Volume
1,235
50D / 200D Avg
$81.21
/
$66.97
Prev Close
$76.58
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 45.5 | 0.4 |
| P/B | 3.5 | 2.9 |
| ROE % | 8.3 | 3.8 |
| Net Margin % | 8.2 | 3.9 |
| Rev Growth 5Y % | 0.1 | 10.0 |
| D/E | 0.6 | 0.2 |
Key Takeaways
Revenue grew 0.12% annually over 5 years — modest growth
Earnings grew 72765.14% over the past year
Generating 810.00M in free cash flow
P/E of 45.47 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 15.01%
Cash machine — converts 111.16% of earnings into free cash flow
Growth
Revenue Growth (5Y)
0.12%
Revenue (1Y)-14.89%
Earnings (1Y)72765.14%
FCF Growth (3Y)N/A
Quality
Return on Equity
8.31%
ROIC6.77%
Net Margin8.24%
Op. Margin15.38%
Safety
Debt / Equity
0.61
Current Ratio1.18
Interest Coverage7.75
Valuation
P/E Ratio
45.47
P/B Ratio3.53
EV/EBITDA27.28
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -14.89% | Revenue Growth (3Y) | -5.89% |
| Earnings Growth (1Y) | 72765.14% | Earnings Growth (3Y) | 207.62% |
| Revenue Growth (5Y) | 0.12% | Earnings Growth (5Y) | -3.21% |
| Profitability | |||
| Revenue (TTM) | 8.84B | Net Income (TTM) | 728.65M |
| ROE | 8.31% | ROA | 3.31% |
| Gross Margin | 47.02% | Operating Margin | 15.38% |
| Net Margin | 8.24% | Free Cash Flow (TTM) | 810.00M |
| ROIC | 6.77% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.61 | Current Ratio | 1.18 |
| Interest Coverage | 7.75 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 45.47 | P/B Ratio | 3.53 |
| P/S Ratio | 3.75 | PEG Ratio | 0.00 |
| EV/EBITDA | 27.28 | Dividend Yield | 0.01% |
| Market Cap | 33.13B | Enterprise Value | 37.08B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 8.84B | 10.38B | 9.98B | 8.60B | 8.79B |
| Net Income | 728.65M | 1.00M | 77.00M | 784.05M | 830.15M |
| EPS (Diluted) | 1.67 | 0.00 | 0.18 | 1.82 | 1.93 |
| Gross Profit | 4.16B | 4.93B | 4.56B | 4.05B | 4.15B |
| Operating Income | 1.36B | 307.00M | 375.00M | 1.15B | 1.38B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 22.03B | 19.91B | 19.43B | 16.23B | 15.98B |
| Total Liabilities | 12.65B | 11.74B | 10.78B | 22,861.0 | 8.55B |
| Shareholders' Equity | 9.38B | 8.16B | 8.65B | 77,139.0 | 7.43B |
| Total Debt | 5.68B | 4.85B | 4.55B | 3.87B | 4.51B |
| Cash & Equivalents | 1.74B | 1.19B | 1.11B | 74.00M | 36.45M |
| Current Assets | 8.17B | 7.80B | 7.57B | 100,000.0 | 5.07B |
| Current Liabilities | 6.90B | 6.31B | 5.70B | 22,861.0 | 7.62B |